GANX - Gain Therapeutics Inc
IEX Last Trade
1.1
0.030 2.727%
Share volume: 555,763
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.07
0.03
2.80%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-16 | 2022-08-08 | 2022-11-10 | 2023-03-23 | 2023-05-12 | 2023-08-10 | 2023-11-14 | 2024-03-26 | |
| Total revenue | 45.006 K | 95.102 K | 0.000 | 0.000 | 55.180 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 45.006 K | 95.102 K | 0.000 | 0.000 | 55.180 K | 0.000 | 0.000 | 0.000 | |
| 111.31% | -100.00% | nan% | inf% | -100.00% | nan% | nan% | |||
| Operating expenses | 3.333 M | 5.271 M | 4.751 M | 4.561 M | 5.285 M | 7.731 M | 4.885 M | 4.407 M | |
| Selling general and admin | 1.777 M | 2.689 M | 2.786 M | 2.287 M | 2.494 M | 3.743 M | 2.518 M | 2.033 M | |
| Research and development | 1.556 M | 2.582 M | 1.965 M | 2.274 M | 2.791 M | 3.988 M | 2.367 M | 2.374 M | |
| Total expenses | 3.333 M | 5.271 M | 4.751 M | 4.561 M | 5.285 M | 7.731 M | 4.885 M | 4.407 M | |
| 58.14% | -9.87% | -3.99% | 15.87% | 46.29% | -36.81% | -9.78% | |||
| Operating income | -3.288 M | -5.176 M | -4.751 M | -4.561 M | -5.230 M | -7.731 M | -4.885 M | -4.407 M | |
| Ebit | -3.288 M | -5.176 M | -4.751 M | -4.561 M | -5.230 M | -7.731 M | -4.885 M | -4.407 M | |
| Pretax income | -3.271 M | -5.076 M | -4.554 M | -4.596 M | -5.121 M | -7.661 M | -4.697 M | -4.709 M | |
| 55.19% | -10.29% | 0.93% | 11.41% | 49.62% | -38.70% | 0.27% | |||
| Income tax | 1.677 K | 9.146 K | 4.048 K | 78.105 K | 16.728 K | 26.589 K | 21.456 K | 14.502 K | |
| Net income basic | -3.273 M | -5.085 M | -4.558 M | -4.674 M | -5.137 M | -7.688 M | -4.718 M | -4.724 M | |
| -55.39% | 10.37% | -2.55% | -9.90% | -49.65% | 38.63% | -0.12% | |||
| Net income | -3.273 M | -5.085 M | -4.558 M | -4.674 M | -5.137 M | -7.688 M | -4.718 M | -4.724 M | |
| -55.39% | 10.37% | -2.55% | -9.90% | -49.65% | 38.63% | -0.12% |